Skip to main contentSkip to navigation
Sirius Investors
Turnstone Biologics Corp.

Turnstone Biologics Corp.

TSBX
NASDAQ•Healthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for TSBX. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Quick links:Overview•Financial Metrics•Technicals•Returns•Financials•Performance

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
11.45M
-95.31% over period
CAGR: -63.90%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
-16.29M
-113.20% over period
CAGR: NaN%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Jun 30, 2025

EV/EBITDA

Potentially Cheap

1.43x

Lower EV/EBITDA can indicate attractive valuation relative to operating earnings.

EV vs Market Cap Spread

-27.74M

EV is -242.3% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: -192.9 pp vs earliest data

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: 2.93x

Share count change in dataset: +3.82%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 202411.45M-16.29M$0.5023.04M
Dec 31, 202351.42M36.84M$2.5520.20M
Dec 31, 2022244.08M214.51M$11.0022.19M
Dec 31, 2021
————

Enterprise Value Analysis

Price Change (Dec 2023 to Dec 2024)

The stock price has decreased from Dec 2023 to Dec 2024.
-80.51%

Recent Volatility

The stock price has been relatively volatile over the last 4 periods, indicating a higher risk profile.
0.37

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
-1.41

Market Cap Change (Dec 2023 to Dec 2024)

The company's market capitalization has decreased from Dec 2023 to Dec 2024.
-77.74%

Enterprise Value Change (Dec 2023 to Dec 2024)

The company's enterprise value has decreased from Dec 2023 to Dec 2024, suggesting a decline in the company's total economic value.
-144.22%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (4 periods), accounting for compounding effects.
-63.90%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (4 periods), accounting for compounding effects.
NaN%